Back to Gastroenterology
Gastroenterologyv2000Evidence-Based

Glasgow-Blatchford Bleeding Score (GBS)

Clinical scoring system to assess the risk of upper gastrointestinal bleeding and identify patients who may need medical intervention such as blood transfusion or endoscopic intervention. Used to stratify patients for safe outpatient management versus hospital admission.

Clinical Input Parameters

mg/dL
Range: 5 — 200 mg/dL
g/dL
Range: 3 — 20 g/dL
mmHg
Range: 50 — 250 mmHg
bpm
Range: 30 — 200 bpm
Clinical Assessment
Awaiting Parameters
gbs score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Glasgow-Blatchford Bleeding Score (GBS) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Total GBS = BUN score + Hemoglobin score (gender-specific) + Systolic BP score + Heart rate score + Melena score + Syncope score + Liver disease score + Heart failure score

Clinical Pearls & Practice Notes

  • Originally developed and validated for predicting need for intervention in upper GI bleeding
  • Score of 0 indicates very low risk and suitability for outpatient management
  • Any score >0 indicates increased risk and potential need for hospital admission
  • Superior to Rockall score for predicting need for intervention
  • Does not require endoscopy to calculate, unlike Rockall score
  • Hemoglobin thresholds differ between men and women
  • Recent studies suggest GBS ≤2 may be safe for outpatient management in some populations
  • Should be used in conjunction with clinical judgment
  • Not validated for variceal bleeding or patients on anticoagulation
  • May be less accurate in elderly patients or those with comorbidities
  • Score should be recalculated if patient condition changes
  • Part of standard care guidelines for upper GI bleeding in UK and Europe
  • Modified versions (mGBS) exist but original version most widely used
  • Can help reduce unnecessary hospital admissions and healthcare costs

Evidence & Literature Citations

  1. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356(9238):1318-1321. doi: 10.1016/S0140-6736(00)02816-6.
  2. Stanley AJ, Ashley D, Dalton HR, et al. Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation. Lancet. 2009;373(9657):42-47. doi: 10.1016/S0140-6736(08)61769-9.
  3. Saltzman JR, Tabak YP, Hyett BH, Sun X, Travis AC, Johannes RS. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc. 2011;74(6):1215-1224. doi: 10.1016/j.gie.2011.06.024.

Score Interpretation Ranges

Low Risk0 – 0 pts

Very low risk - Safe for outpatient management

Low-Moderate Risk1 – 5 pts

Low to moderate risk requiring clinical assessment

Moderate Risk6 – 11 pts

Moderate risk requiring hospital admission

High Risk12 – 23 pts

High risk requiring immediate intervention

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.